Title of article
Heparin and aspirin attenuate placental apoptosis in vitro: Implications for early pregnancy failure
Author/Authors
Patrick Bose، نويسنده , , Simon Black، نويسنده , , Mamed Kadyrov، نويسنده , , Ute Weissenborn، نويسنده , , Joseph Neulen، نويسنده , , Lesley Regan، نويسنده , , Berthold Huppertz، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2005
Pages
8
From page
23
To page
30
Abstract
Objective
Live birth rates are increased by treatment with heparin and aspirin in cases of poor pregnancy outcome such as antiphospholipid syndrome. Both drugs may attenuate miscarriage by inhibiting aberrant coagulation or by modulating trophoblast apoptosis. Here we assessed their roles in trophoblast apoptosis in vitro.
Study design
BeWo cells and placental villi were cultured in sera from women with successful or failing in vitro fertilization, with and without heparin or aspirin. Apoptosis was assessed by using DNA laddering, cytokeratin 18 neoepitope formation, Bcl-2, and caspase 7 expression.
Results
In BeWo cells, sera from in vitro fertilization failure increased trophoblast apoptosis, whereas heparin and aspirin reversed these effects. In villous trophoblast, heparin increased Bcl-2 and cytokeratin 18 protein expression. Heparin and aspirin inhibited DNA laddering.
Conclusion
Heparin and aspirin modulate trophoblast apoptosis suggesting a direct impact on trophoblast biology, thus providing an additional mechanism to explain the clinical benefits of heparin and aspirin on recurrent pregnancy loss.
Keywords
ApoptosisBcl-2Cytokeratin-18neoepitopeCaspase 7Human sera
Journal title
American Journal of Obstetrics and Gynecology
Serial Year
2005
Journal title
American Journal of Obstetrics and Gynecology
Record number
644532
Link To Document